Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort

The atypical antipsychotic (AAP) class is often associated with metabolic disease, but the mechanistic underpinnings of this risk are not understood. Due to reports linking gut bacteria function to metabolic disease, we hypothesize that AAP treatment in adults results in gut dysbiosis potentiating metabolic criteria. This report describes recent findings linking AAP treatment with differences in gut microbiota communities in a human cohort with bipolar disorder (BD).

[1]  Keishi Kameyama,et al.  Intestinal Colonization by a Lachnospiraceae Bacterium Contributes to the Development of Diabetes in Obese Mice , 2014, Microbes and environments.

[2]  D. Andersen,et al.  Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass. , 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[3]  J. Kirby,et al.  Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children , 2015, Translational Psychiatry.

[4]  Craig W. Colton,et al.  Congruencies in Increased Mortality Rates, Years of Potential Life Lost, and Causes of Death Among Public Mental Health Clients in Eight States , 2006, Preventing chronic disease.

[5]  J. Lieberman,et al.  Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1 , 2008, Schizophrenia Research.

[6]  John M. Davis,et al.  Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients , 2012, Psychiatry Research.

[7]  J. Lieberman,et al.  Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III , 2005, Schizophrenia Research.

[8]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[9]  A. Xu,et al.  Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice , 2016, Circulation.

[10]  T. Dinan,et al.  Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat , 2013, Translational Psychiatry.

[11]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[12]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[13]  R. Brook,et al.  Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population , 2014, Bipolar disorders.

[14]  R. Gomis,et al.  Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice , 2015, Scientific Reports.

[15]  D. Raoult,et al.  Repertoire of human gut microbes. , 2017, Microbial pathogenesis.

[16]  Y. Cho.  A Gut Feeling to Cure Diabetes: Potential Mechanisms of Diabetes Remission after Bariatric Surgery , 2014, Diabetes & metabolism journal.

[17]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[18]  A. Seeringer,et al.  Sex-specific differences in side effects of psychotropic drugs: genes or gender? , 2009, Pharmacogenomics.

[19]  J. Lieberman,et al.  Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study , 2008, Schizophrenia Research.

[20]  R. D. de Souza,et al.  Colonic Health: Fermentation and Short Chain Fatty Acids , 2006, Journal of clinical gastroenterology.

[21]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[22]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[23]  Sur Herrera Paredes,et al.  The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse , 2014, PloS one.

[24]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[25]  T. Dinan,et al.  Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters , 2012, Psychopharmacology.

[26]  H. Hinterhuber,et al.  Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents. , 2007, Journal of child and adolescent psychopharmacology.

[27]  Melvin G McInnis,et al.  Interaction between COMT rs5993883 and second generation antipsychotics is linked to decreases in verbal cognition and cognitive control in bipolar disorder , 2016, BMC Psychology.

[28]  Rob Knight,et al.  UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..

[29]  M. Rickels,et al.  Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease , 2013, Diabetes.

[30]  K. Teff,et al.  Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism , 2011, Physiology & Behavior.

[31]  Jack C. Yue,et al.  A Similarity Measure Based on Species Proportions , 2005 .

[32]  Lucie Geurts,et al.  Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity , 2013, Proceedings of the National Academy of Sciences.

[33]  L. Excoffier,et al.  Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. , 1992, Genetics.

[34]  Martin Hartmann,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[35]  J. Lieberman,et al.  A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls , 2005, Schizophrenia Research.

[36]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.